Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital changed +61.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Current assets changed +65.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed +44.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Inventory changed +35.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Cash & equivalents changed +95.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Trade receivables changed +32.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating income changed +200.9% from the comparable as-filed period.
Operating margin changed +941 basis points from the comparable as-filed period.
Noncurrent long-term debt changed +99.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross margin changed +412 basis points from the comparable as-filed period.
Operating cash flow changed +88.1% from the comparable as-filed period.
Shares outstanding changed +6.2% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Revenue changed +30.0% from the comparable as-filed period.
Free-cash-flow proxy changed +107.6% from the comparable as-filed period.
Current liabilities changed +78.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross profit changed +44.5% from the comparable as-filed period.
Working capital / assets changed +546 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Stock-based compensation changed +57.4% from the comparable as-filed period.
Capital expenditure changed +76.2% from the comparable as-filed period.
Capex / revenue changed +226 basis points from the comparable as-filed period.
Inventory / revenue changed +360 basis points from the comparable as-filed period.
Cost of revenue changed +21.5% from the comparable as-filed period.
Operating cash-flow margin changed +457 basis points from the comparable as-filed period.
Research & development changed +10.2% from the comparable as-filed period.
Free-cash-flow margin changed +231 basis points from the comparable as-filed period.
Selling, general & administrative changed +15.3% from the comparable as-filed period.
R&D / revenue changed -204 basis points from the comparable as-filed period.
Receivables / revenue changed +145 basis points from the comparable as-filed period.
SBC / revenue changed +65 basis points from the comparable as-filed period.
Current ratio changed -7.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.